Ticagrelor Administered as Standard Tablet or Orodispersible Formulation

NCT03822377 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
130
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Azienda Ospedaliero Universitaria di Sassari

Collaborators